Unusual outcome of treatment of thymoma with immunotherapy: case report
Mohamed Shanshal, Joseph Maakaron, Kaushal Parikh, Jenesse Nicole Moffett, Ailsa G Luce, Anna J Schwecke, Julian Molina, Konstantinos Leventakos · 2024
Read Unusual outcome of treatment of thymoma with immunotherapy: case report by Mohamed Shanshal, Joseph Maakaron, Kaushal Parikh, Jenesse Nicole Moffett, Ailsa G Luce, Anna J Schwecke, Julian Molina, Konstantinos Leventakos (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11707440.txt.
Description
Mohamed Shanshal and co-authors tell a 2024 case story of a thymus tumor that answered immune therapy in an unusual way. Thymomas are rare chest tumors often paired with autoimmune syndromes. Immune checkpoint drugs tend to spark severe side effects in such patients, so trials have shunned them.
The patient first gained a brief partial response from standard chemotherapy. She then developed aplastic anemia tied to the tumor, as her marrow failed. An immune-suppressing drug did not halt the decline, and later chemo rounds also failed as the tumor spread across the chest lining. Doctors then tried the checkpoint drug atezolizumab. No response came while the suppressant ran, but after it stopped, the tumor showed a striking response. The case questions blanket bans.
Catalog record
| CREATOR | Mohamed Shanshal, Joseph Maakaron, Kaushal Parikh, Jenesse Nicole Moffett, Ailsa G Luce, Anna J Schwecke, Julian Molina, Konstantinos Leventakos |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |